New Stock Issue

Cara Therapeutics(CARA), Ultragenyx Pharmaceutical(RARE), Trevena(TRVN), Celladon(CLDN), Dicerna Pharmaceutical(DRNA), Akers Biosciences(AKER), Glycomimetics(GLYC), Retrophin(RTRX), Varonis Systems(VRNS), Lumenis(LMNS), Semler Scientific(SMLR), Inogen(INGN), Amedica(AMDA), Concert Pharmaceutical(CNCE), Eagle Pharmaceutical(EGRX), Flexion Therapeutic(FLXN), Talmer Bancorp(TLMR), Nephrogenex(NRX), Argos Therapeutic(ARGS), Eleven Biotherapeutic(EBIO), Egalet Corp(EGLT), Revance Therapeutic(RVNC), Uniqure(QURE), Genocea Biosciences(GNCA), Auspex Pharmaceutical(ASPX), Biocept(BIOC), 2U Inc(TWOU), Energous Corp(WATT), Square 1 Financial(SQBK), Applied Genetic Technologies(AGTC), Borderfree(BRDR), Ruthigen(RTGN), Versartis(VSAR), Akebia Therapeutic(AKBA), Mediwound(MDWD), Paylocity Holding(PCTY), Ignyta(RXDX), Dipexium Pharmaceutical(DPRX), Galmed Pharmaceutical(GLMD), Achaogen(AKAO), Aquinox Pharmaceutical(AQXP), Recro Pharma(REPH), The New Home Company(NWHM), Intrawest Resorts(SNOW), North Atlantic Drilling(NADL), Care.com(CRCM), Santander Consumer USA(SC), RSP Permian(RSPP), EP Energy(EPE), CHC Group(HELI), Cypress Energy Partners(CELP), Installed Building Products(IBP), Geopark(GPRK), Ladder Capital(LADR), Continental Building Products(CBPX), CBS Outdoor Americas(CBSO), Everyday Health(EVDY), Aerohive Networks(HIVE), Trinet Group(TNET), King Digital Entertainment(KING), Nord Anglia Education(NORD), Amber Road(AMBR), A10 Networks(ATEN), Q2 Holdings(QTWO), Castlight Health(CSLT), Coupons.com(COUP), Bluerock Residential Growth(BRG).